Schizophyllan & Cancer
Explore mushroom research and guides on schizophyllan & cancer.
How Schizophyllan Enhances Anti-Tumor Immunity
How schizophyllan works against cancer: macrophage activation via Dectin-1, the triple-helix structure requirement, and why high doses paradoxically fail.
Schizophyllan and Cancer: Japan's Approved Anti-Cancer Drug
Schizophyllan is a prescription cancer drug in Japan with controlled trial evidence for gastric, cervical, and head and neck cancers. Not FDA-approved.
Schizophyllan and Gastric Cancer: Adjunct Therapy Evidence
Two Japanese RCTs found schizophyllan improved gastric cancer 5-year survival, with significant Stage III benefit in the larger trial. What the evidence shows.
Schizophyllan vs. Lentinan: Comparing Mushroom Cancer Drugs
Schizophyllan and lentinan are both approved Japanese mushroom cancer drugs with triple-helix beta-glucan structures and RCT evidence. Here's how they compare.
SPG for Cervical Cancer: Japanese Clinical Trial Results
Okamura 1986 (220 patients, Cancer journal) and Noda 1992 (312 patients, 19 institutions) showed schizophyllan improved survival in Stage II cervical cancer.